Astrana Health ASTH
Nasdaq · Services-Management Consulting ServicesData provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
1 story has a settled next close so far (1 on the Wire). The record starts speaking at three.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via DatabentoOperating leverage — margins
| Line Item (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY Δ | 4Y CAGR | Trend |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | $773.9M | $1.1B | $1.4B | $2.0B | $3.2B | +56.4% | +42.4% | |
| Cost of Revenue (COGS) | $596.1M | — | — | — | $596.1M | — | +0.0% | |
| Operating Income (EBIT) | $98.2M | $104.3M | $84.6M | $89.3M | $78.5M | −12.1% | −5.4% | |
| Interest Expense | $5.4M | $7.9M | $16.1M | $33.1M | $49.9M | +50.9% | +74.4% | |
| Income Tax Expense | $31.7M | $40.9M | $32.0M | $30.9M | $15.5M | −49.7% | −16.3% | |
| GAAP Net Income | $46.0M | $46.0M | $58.0M | $50.0M | $24.0M | −52.0% | −15.0% | |
| Diluted EPS | $1.52 | $0.99 | $1.29 | $0.90 | $0.46 | −48.9% | −25.8% | |
| Diluted Shares | 45.4M | 45.6M | 46.9M | 48.0M | 49.4M | +2.9% | +2.1% | |
| Balance Sheet | ||||||||
| Cash & Equivalents | $233.1M | $288.0M | $294.2M | $289.1M | $434.0M | +50.1% | +16.8% | |
| Total Current Assets | $404.5M | $428.1M | $461.5M | $638.5M | $863.3M | +35.2% | +20.9% | |
| Total Assets | $867.4M | $966.2M | $933.4M | $1.4B | $2.2B | +63.8% | +26.5% | |
| Total Current Liabilities | $114.7M | $148.6M | $218.7M | $365.6M | $615.3M | +68.3% | +52.2% | |
| Total Debt (Short + Long Term) | $183.7M | $204.0M | $278.4M | $434.7M | $1.0B | +139.0% | +54.2% | |
| Total Liabilities | $356.7M | $407.7M | $522.6M | $840.7M | $1.7B | +97.5% | +46.9% | |
| Stockholders' Equity | $454.1M | $544.3M | $616.7M | $716.7M | $793.3M | +10.7% | +15.0% | |
| Net Cash / (Net Debt) | $49.4M | $84.0M | $15.7M | $-145.6M | $-604.7M | −315.4% | — | |
| Invested Capital | $404.7M | $460.3M | $600.9M | $862.3M | $1.4B | +62.1% | +36.3% | |
| Cash Flow & Capital Allocation | ||||||||
| Operating Cash Flow (OCF) | $70.3M | $82.1M | $68.2M | $52.2M | $114.6M | +119.5% | +13.0% | |
| Depreciation & Amortization (D&A) | $17.5M | $17.5M | $17.7M | $27.9M | $45.7M | +63.8% | +27.1% | |
| Stock-Based Compensation (SBC) | $6.7M | $16.1M | $22.0M | $34.5M | $38.6M | +11.8% | +54.7% | |
| Capital Expenditures (CapEx) | $19.2M | $22.9M | $28.5M | $8.0M | $10.1M | +25.8% | −14.8% | |
| Free Cash Flow (FCF) | $51.1M | $59.2M | $39.7M | $44.2M | $104.5M | +136.6% | +19.6% | |
| True FCF (ex-SBC Owner Cash) | $44.4M | $43.1M | $17.7M | $9.6M | $65.9M | +584.1% | +10.4% | |
| Share Repurchases (Buybacks) | $5.7M | $9.3M | $10.2M | $900,000 | $25.6M | +2744.4% | +45.3% | |
| Dividends Paid | $31.1M | $14.0M | $62.1M | $4.0M | $7.9M | +95.4% | −29.0% | |
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.